全文获取类型
收费全文 | 2559337篇 |
免费 | 198242篇 |
国内免费 | 4303篇 |
专业分类
耳鼻咽喉 | 35575篇 |
儿科学 | 79591篇 |
妇产科学 | 66508篇 |
基础医学 | 352960篇 |
口腔科学 | 69493篇 |
临床医学 | 229337篇 |
内科学 | 501704篇 |
皮肤病学 | 49038篇 |
神经病学 | 218332篇 |
特种医学 | 104707篇 |
外国民族医学 | 886篇 |
外科学 | 390091篇 |
综合类 | 58790篇 |
现状与发展 | 2篇 |
一般理论 | 1001篇 |
预防医学 | 209046篇 |
眼科学 | 58783篇 |
药学 | 187926篇 |
54篇 | |
中国医学 | 5060篇 |
肿瘤学 | 142998篇 |
出版年
2018年 | 44399篇 |
2017年 | 34682篇 |
2016年 | 38413篇 |
2015年 | 24838篇 |
2014年 | 35297篇 |
2013年 | 52873篇 |
2012年 | 76961篇 |
2011年 | 92917篇 |
2010年 | 60038篇 |
2009年 | 52029篇 |
2008年 | 87649篇 |
2007年 | 93979篇 |
2006年 | 76316篇 |
2005年 | 75648篇 |
2004年 | 74071篇 |
2003年 | 72493篇 |
2002年 | 69906篇 |
2001年 | 112918篇 |
2000年 | 117060篇 |
1999年 | 98708篇 |
1998年 | 28298篇 |
1997年 | 25939篇 |
1996年 | 25754篇 |
1995年 | 24882篇 |
1994年 | 23415篇 |
1993年 | 21766篇 |
1992年 | 79544篇 |
1991年 | 76584篇 |
1990年 | 73781篇 |
1989年 | 70984篇 |
1988年 | 65997篇 |
1987年 | 64926篇 |
1986年 | 61431篇 |
1985年 | 58518篇 |
1984年 | 44333篇 |
1983年 | 37788篇 |
1982年 | 23039篇 |
1981年 | 20438篇 |
1980年 | 19170篇 |
1979年 | 41361篇 |
1978年 | 29072篇 |
1977年 | 24432篇 |
1976年 | 22898篇 |
1975年 | 24036篇 |
1974年 | 29714篇 |
1973年 | 28086篇 |
1972年 | 26267篇 |
1971年 | 24178篇 |
1970年 | 22790篇 |
1969年 | 21119篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
121.
122.
Sofosbuvir and velpatasvir with or without voxilaprevir in direct‐acting antiviral‐naïve chronic hepatitis C: patient‐reported outcomes from POLARIS 2 and 3 下载免费PDF全文
123.
124.
Serum pepsinogen 1 and anti‐Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males 下载免费PDF全文
125.
126.
Cost‐Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States 下载免费PDF全文
127.
128.
Eyal Schwartzberg Joseph P. Nathan Sivan Avron Eli Marom 《Israel journal of health policy research》2018,7(1):59
The community pharmacy setting is a venue that is readily accessible to the public. In addition, it is staffed by a pharmacist, who is a healthcare provider, trained and capable of delivering comprehensive pharmaceutical care. As such, community pharmacists have a colossal opportunity to serve as key contributors to patients’ health by ensuring appropriate use of medications, preventing medication misadventures, identifying drug-therapy needs, as well as by being involved in disease management, screening, and prevention programs. This unique position gives the pharmacist the privilege and duty to serve patients in roles other than solely that of the stereotypical drug dispenser.Worldwide, as well as in Israel, pharmacists already offer a variety of pharmaceutical services and tend to patients’ and the healthcare system’s needs. This article provides examples of professional, clinical or other specialty services offered by community pharmacists around the world and in Israel and describes these interventions as well as the evidence for their efficacy. Examples of such activities which were recently introduced to the Israeli pharmacy landscape due to legislative changes which expanded the pharmacist’s scope of practice include emergency supply of medications, pharmacists prescribing, and influenza vaccination. Despite the progress already made, further expansion of these opportunities is warranted but challenging. Independent prescribing, as practiced in the United Kingdom or collaborative drug therapy management programs, as practiced in the United States, expansion of vaccination programs, or wide-spread recognition and reimbursement for medication therapy management (MTM) programs are unrealized opportunities. Obstacles such as time constraints, lack of financial incentives, inadequate facilities and technology, and lack of professional buy-in, and suggested means for overcoming these challenges are also discussed. 相似文献
129.
There is keen interest in many jurisdictions in finding ways to improve the way that research evidence informs policy. One possible mechanism for this is to embed academics within government agencies either as advisers or full staff members. Our commentary argues that, in addition to considering the role of academics in government as proposed by Glied and colleagues, we need to understand better how research and policy interactions function across policy sectors. We believe more comparative research is needed to understand if and why academics from certain disciplines are more likely to be recruited to work in some policy sectors rather than others. We caution against treating government as monolithic by advocating the same model for collaborative interaction between academics and government. Lastly, we contend that contextualized research is needed to illuminate important drivers of research and policy interactions before we can recommend what is likely to be more and less effective in different policy sectors. 相似文献
130.